Amplification of CCND1 and expression of its protein product, cyclin D1, in ductal carcinoma in situ of the breast

American Journal of Pathology

Volumn 151, Issue 1, 1997, Pages 161-168

  Simpson, Jean F ^a,c   Quan, Diane E ^a   O'Malley, Frances ^a   Odom Maryon, Tamara ^b   Clarke, Patrick E ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^b LONDON HEALTH SCIENCES CENTRE   (Canada)

^c VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1;

ANEUPLOIDY; ARTICLE; BREAST BIOPSY; BREAST CARCINOMA; BREAST DUCT; CANCER GRADING; CANCER INVASION; CELL CYCLE G1 PHASE; GENE AMPLIFICATION; GENE EXPRESSION REGULATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LABELING INDEX; MAMMOGRAPHY; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEM CELL;

ANALYSIS OF VARIANCE; BREAST NEOPLASMS; CARCINOMA IN SITU; CARCINOMA, DUCTAL, BREAST; CYCLIN D1; CYCLINS; GENE AMPLIFICATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; MULTICENTER STUDIES; ONCOGENE PROTEINS;

EID: 0030785841     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Page DL, Dupont WD, Rogers LW, Jensen RA, Schuyler PA: Continued local recurrence of carcinoma 15-25 years after a diagnosis of low grade ductal carcinoma in situ of the breast treated only by biopsy. Cancer 1995; 76:1197-1200
2. Page DL, Dupont WD, Rogers LW, Landenberger M: Intraductal carcinoma of the breast: follow-up after biopsy only. Cancer 1982; 49:751-758
3. Lagios MD, Margolin FR, Westdahl PR, Rose MR: Mammographically detected duct carcinoma in situ: frequency of local recurrence following tylectomy and prognostic effect of nuclear grade on local recurrence. Cancer 1989; 63:618-624
4. Schwartz GF, Finkel GC, Garcia JC, Patchefsky AS: Subclinical ductal carcinoma in situ of the breast: treatment by excision and surveillance alone. Cancer 1992; 70:2468-2474
5. Bellamy COC, McDonald C, Salter DM, Chetty U, Anderson TJ: Noninvasive ductal carcinoma of the breast: the relevance of histologie categorization. Hum Pathol 1993; 24:16-23
6. Millis RR, Bobrow LG, Barnes DM: Immunohistochemical evaluation of biological markers in mammary carcinoma in situ: correlation with morphological features and recently proposed schemes for histological classification. Breast 1996; 5:113-122
7. Pines J. Cyclins: wheels within wheels. Cell Growth Differ 1991; 2:305-310.
8. Sutherland RL, Watts CKW, Musgroye EA: Cyclin gene expression and growth control in normal and neoplastic human breast epithelium. J Steroid Biochm Mol Biol 1993; 47:1-6
9. Fantl V, Richards MA, Smith R, Lammie GA, Johnstone G, Allen D, Gregory W, Peters G, Dickson C, Barnes DM: Gene amplification on chromosome band 11q13 and oestrogen receptor status in breast cancer. Eur J Cancer 1990; 26:423-429
10. Lammie GA, Fantl V, Smith RJ, Schuuring E, Brookes S, Michalides R, Dickson C, Arnold A, Peters G: D11S287, a putative oncogene on chromosome 11q13, is amplified and expressed in squamous cell and mammary carcinomas and linked to BCL-1. Oncogene 1991; 6:439-444
11. Weinstat-Saslow D, Merino MJ, Manrow RE, Lawrence JA, Bluth RF, Wittenbel KD, Simpson JF, Page DL, Steeg PS: Overexpression of cyclin D mRNA distinguishes invasive and in situ breast carcinomas from non-malignant lesions. Nature Med 1995; 1:1257-1260
12. Scott M, Axelsson K, Lagios MD, Anderson T, Rogers L, Page DL: Ductal carcinoma in situ of the breast, reproducibility of histologie subtype analysis. Mod Pathol 1995; 8:25A
13. Silverstein MJ, Lagios MD, Craig PH, Waisman JR, Lewinsky BS, Colburn WJ, Poller DN: A prognostic index for ductal carcinoma in situ of the breast. Cancer 1996; 77:2267-2274
14. Silverstein MJ, Poller DN, Waisman JR, Coiburn WJ, Earth A, Gierson ED, Lewinsky B, Gamagami P, Slamon DJ: Prognostic classification of breast ductal carcinoma-in-situ. Lancet 1995; 345:1154-1157
15. Buckley MJ, Sweeney KJE, Hamilton JA, Sini RL, Manning DL, Nicholson Rl, deFazio A, Watts CKW, Musgrove EA, Sutherland RL: Expression and amplification of cyclin genes in human breast cancer. Oncogene 1993; 8:2127-2133
16. Inaba T, Matsushime H, Valentine M, Roussel MF, Sherr CJ, Look AT: Genomic organization, chromosome location, and independent expression of human cyclin D genes. Genomics 1992; 13:565-574
17. Press MF, Pike MC, Hung G, Zhou JY, Ma Y, George J, Dietz-Band J, James W, Slamon DJ, Batsakis JG, ElNaggar AK: Amplification and overexpression of HER2/neu in carcinomas of the salivary gland: correlation with poor prognosis. Cancer Res 1994; 54:5675-5682
18. Saffari B, Jones LA, EI-Naggar A, Felix JC, George J, Press MF: Amplification and overexpression of HER-2/ neu (c-erbB2) in endometrial cancers: correlation with overall survival. Cancer Res 1995; 55:5693-5698
19. Gown A, de Wever N, Battifora H: Microwave-based antigenic unmasking: a revolutionary new technique for routine immunohistochemistry. Appl Immunol 1993; 1:256-266
20. Borg A, Sigurdsson H, Clark GM, Ferno M, Fuqua SAW, Olsson H, Killander D, McGuire WL: Association of INT2/HST1 coamplification in primary breast cancer with hormone-dependent phenotype and poor prognosis. Br J Cancer 1991; 63:136-142
21. Gillett CE, Fantl V, Smith R, Fisher C, Bartek J, Dickson C, Barnes D, Peters G: Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining. Cancer Res 1994; 54:18121817
22. Zhang S-Y, Caamano J, Cooper F, Klein-Szanto JP: Immunohistochemistry of cyclin D in human breast cancer. Am J Clin Pathol 1994; 102:695-698
23. Mclntosh GG, Anderson JJ, Milton I, Steward M, Parr AH, Thomas MD, Henry JA, Angus B, Lennard TWJ, Hörne CHW: Determination of the prognostic value of . cyclin D1 overexpression in breast cancer. Oncogene 1995; 11:885-891
24. Bartkova J, Lukas J, Muller H, Lutzhoft D, Strauss M, Bartek J. Cyclin D1 protein expression and function in human breast cancer. Int J Cancer 1994; 57:353-361
25. Sicinski P, Donaher JL, Parker SB, Li T, Fazeli A, Gardner H, Haslam SZ, Bronson RT, Elledge SJ, Weinberg RA: Cyclin D1 provides a link between development and oncogenesis in the retina and breast. Cell 1995; 82:621-630
26. Wang TC, Cardiff RD, Zukerberg L, Lees E, Arnold A, Schmidt EV: Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice. Nature 1994; 369: 669-671
27. AN IU, Merlo G, Callahan R, Lidereau R: The amplification unit on chromosome 11q13 in aggressive primary human breast tumors entails the bcl-1, int-2, and hst loci. Oncogene 1989; 4:89-92
28. Schuuring E, Verhoeven E, Mooi WJ, Michalides RJAM: Identification and cloning of two over-expressed genes, U21B31/PRAD1 and EMS1, within the amplified chromosome 11q13 region in human carcinomas. Oncogene 1992; 7:355-361
29. Meyer JS. Cell kinetics of histologie variants of in situ breast carcinoma. Breast Cancer Res Treat 1986; 7:171-180
30. Sherr CJ: G1 phase progression: cycling on cue. Cell 1994; 79:551-555
31. Pagano M, Theodoraas AM, Tarn SW, Dretta GF: Cyclin D1-mediated inhibition of repair and replicative DNA synthesis in human fibroblasts. Genes Dev 1994; 8:1627-1639
32. Lukas J. Pagano M, Staskova Z, Draetta G, Bartek J: Cyclin D1 protein oscillates and is essential for cell cycle progression in human tumour cell lines. Oncogene 1994; 9:707-718
33. Han EK-H, Sgambato A, Jiang W, Zhang Y-J, Santella RM, Doki Y, Cacace AM, Schieren l, Weinstein IB: Stable overexpression of cyclin D1 in a human mammary epithelial cell line prolongs the S-phase and inhibits growth. Oncogene 1995; 10:953-961
34. Peters G: The D-type cyclins and their role in tumorigenesis. J Cell Sei 1994; 18:89-96
35. Hunter T, Pines J: Cyclins and cancer II: cyclin D and CDK inhibitors come of age. Cell 1994; 79:573-582
36. Said TK, Luo L, Medina D: Mouse mammary hyperplasias and neoplasias exhibit different patterns of cyclin D1 and D2 binding to cdk4. Carcinogenesis 1995; 16:2507-2513
37. Chen X, Bargonetti J, Prives C: p53, through p21 (WAF1/CIP1), induces cyclin D1 synthesis. Cancer Res 1995; 55:4257-4263